Each stage of the life cycle of a company or a product presents challenges that demand the expertise and resources of a strong legal partner. Be it putting your intellectual property portfolio in order, assessing fi nancing strategies to market your products, or defending your IP rights, legal issues play a large role in the success of Canada's life sciences and pharma companies.
In the sixth edition of Current Issues, members of our life sciences team look at legal trends in Canada and around the world at various stages of the life cycle, from start-up through to maturity. Many of the challenges that arise are not local. Developments in Europe or the U.S. may impact business strategies for companies in Canada. That's why we've included a number of comparison pieces to help clients determine which fi ling strategies work best for them or which markets they should target. We're also pleased to include a contribution from our Moscow offi ce, which celebrated its 20th anniversary in Russia last year.
In a recent exercise, we mapped out 40 unique potential legal "events" in a company's life cycle. An organization's needs at different stages of the life cycle will depend on its stage of development, overall business strategy and market conditions. External factors play a large role: the economy impacts fi nancing strategies, and recent court decisions will impact litigation strategies. Gowlings is able to provide legal support at each stage of the life cycle to help you succeed.
It is for these reasons we continue to be an important partner in the development and success of your business. We hope you fi nd the articles in this year's Current Issues helpful, relevant and timely as your company moves through its life cycle, and we invite you to contact any member of our team with questions.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
